McFarlane Neil F.

Chief Operating Officer at Travere Therapeutics, Inc. · on record since Aug 15, 2016
Director at ZEVRA THERAPEUTICS, INC. · on record since Oct 11, 2023
President and CEO at ZEVRA THERAPEUTICS, INC. · on record since Oct 11, 2023
Chief Executive Officer at Adamas Pharmaceuticals Inc · on record since Sep 17, 2019
Director at Adamas Pharmaceuticals Inc · on record since Nov 24, 2021
Director at COLLEGIUM PHARMACEUTICAL, INC · on record since May 23, 2022

Insider trading activity of McFarlane Neil F.

Transactions on record: 49; since Aug 15, 2016

Open-market buys: 0

Open-market sells: 12; $2.5M

Companies traded: 4; last filing Feb 10, 2026

Figures computed from official regulatory filings — .

Companies where McFarlane Neil F. has traded

ZEVRA THERAPEUTICS, INC.20 tx · $1.9M · Feb 10, 2026
COLLEGIUM PHARMACEUTICAL, INC4 tx · May 16, 2024
Adamas Pharmaceuticals Inc9 tx · Nov 24, 2021
Travere Therapeutics, Inc.16 tx · $552.6K · May 16, 2019

Track record of McFarlane Neil F.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of McFarlane Neil F.

Co-insiders of McFarlane Neil F.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 10, 2026	Sell	-14,625	8.56 USD	$125.2K		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 10, 2026	Exercise	37,500	—	n/a (No price was disclosed in the filing)		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 10, 2026	ExerciseD (derivative)	-37,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 2, 2026	AwardD (derivative)	125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 2, 2026	Sell	-91,000	9.38 USD	$853.6K	Unusual size	SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 2, 2026	ExerciseD (derivative)	-233,334	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 2, 2026	Exercise	233,334	—	n/a (No price was disclosed in the filing)		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 2, 2026	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Oct 10, 2025	Sell	-19,500	10.82 USD	$211K		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Oct 10, 2025	Exercise	50,000	—	n/a (No price was disclosed in the filing)		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Oct 10, 2025	ExerciseD (derivative)	-50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 14, 2025	Sell	-30,544	8.05 USD	$245.9K		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 14, 2025	Sell	-61,273	7.86 USD	$481.6K	Unusual size	SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 10, 2025	AwardD (derivative)	225,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 10, 2025	AwardD (derivative)	112,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 3, 2025	Exercise	233,333	—	n/a (No price was disclosed in the filing)		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 3, 2025	ExerciseD (derivative)	-233,333	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
COLLEGIUM PHARMACEUTICAL, INCListing on record	May 16, 2024	Award	7,693	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 2, 2024	AwardD (derivative)	700,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Oct 11, 2023	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Oct 11, 2023	AwardD (derivative)	600,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
COLLEGIUM PHARMACEUTICAL, INCListing on record	May 19, 2023	Award	9,792	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
COLLEGIUM PHARMACEUTICAL, INCListing on record	May 23, 2022	Award	14,035	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
COLLEGIUM PHARMACEUTICAL, INCListing on record	Apr 8, 2022	Award	17,845	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	OtherD (derivative)	-250,000	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 10, 2026	Sell	-14,625	8.56 USD	$125.2K		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 10, 2026	Exercise	37,500	—	n/a (No price was disclosed in the filing)		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 10, 2026	ExerciseD (derivative)	-37,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 2, 2026	AwardD (derivative)	125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 2, 2026	Sell	-91,000	9.38 USD	$853.6K	Unusual size	SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 2, 2026	ExerciseD (derivative)	-233,334	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 2, 2026	Exercise	233,334	—	n/a (No price was disclosed in the filing)		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 2, 2026	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Oct 10, 2025	Sell	-19,500	10.82 USD	$211K		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Oct 10, 2025	Exercise	50,000	—	n/a (No price was disclosed in the filing)		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Oct 10, 2025	ExerciseD (derivative)	-50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 14, 2025	Sell	-30,544	8.05 USD	$245.9K		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 14, 2025	Sell	-61,273	7.86 USD	$481.6K	Unusual size	SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 10, 2025	AwardD (derivative)	225,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 10, 2025	AwardD (derivative)	112,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 3, 2025	Exercise	233,333	—	n/a (No price was disclosed in the filing)		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 3, 2025	ExerciseD (derivative)	-233,333	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
COLLEGIUM PHARMACEUTICAL, INCListing on record	May 16, 2024	Award	7,693	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Feb 2, 2024	AwardD (derivative)	700,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Oct 11, 2023	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Oct 11, 2023	AwardD (derivative)	600,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
COLLEGIUM PHARMACEUTICAL, INCListing on record	May 19, 2023	Award	9,792	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
COLLEGIUM PHARMACEUTICAL, INCListing on record	May 23, 2022	Award	14,035	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
COLLEGIUM PHARMACEUTICAL, INCListing on record	Apr 8, 2022	Award	17,845	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	OtherD (derivative)	-250,000	—	n/a (No price was disclosed in the filing)		SEC